Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience.
Alonso García L, Bueno Sánchez D, Fernández Navarro JM, Regueiro Garcia A, Blanquer Blanquer M, Benitez Carabante MI, Mozo Del Castillo Y, Fuster Soler JL, Uria Oficialdegui ML, Sisinni L, Perez Martinez A, Diaz de Heredia Rubio C. Alonso García L, et al. Among authors: blanquer blanquer m. Front Immunol. 2024 Feb 1;15:1307932. doi: 10.3389/fimmu.2024.1307932. eCollection 2024. Front Immunol. 2024. PMID: 38370416 Free PMC article.
Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia.
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortés MB, Llinares ME, Jiménez I, Plaza M, Martínez Banaclocha H, Galián JA, Blanquer Blanquer M, Martínez Sánchez MV, Muro M, Minguela A. Ramos Elbal E, et al. Among authors: blanquer blanquer m. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. Clin Transl Oncol. 2024. PMID: 37368200
Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia.
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortés MB, Llinares ME, Jiménez I, Plaza M, Banaclocha HM, Galián JA, Blanquer Blanquer M, Martínez Sánchez MV, Muro M, Minguela A. Ramos Elbal E, et al. Among authors: blanquer blanquer m. Clin Transl Oncol. 2023 May;25(5):1446-1454. doi: 10.1007/s12094-022-03042-z. Epub 2023 Jan 4. Clin Transl Oncol. 2023. PMID: 36598635
Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis.
Sánchez Villalobos M, Salido Fiérrez E, Martínez Nieto J, García Garay MC, Beltrán Videla A, Pérez Oliva AB, Blanquer Blanquer M, Moraleda Jiménez JM. Sánchez Villalobos M, et al. Among authors: blanquer blanquer m. Hematol Rep. 2022 Oct 8;14(4):300-304. doi: 10.3390/hematolrep14040043. Hematol Rep. 2022. PMID: 36278520 Free PMC article.
Mantle cell lymphoma involving the breast in a male patient.
Ruiz Pardo J, López López V, Blanquer Blanquer M, Cabezas Herrera J, Piñero Madrona A. Ruiz Pardo J, et al. Among authors: blanquer blanquer m. Cir Esp. 2017 Mar;95(3):170-172. doi: 10.1016/j.ciresp.2016.06.007. Epub 2016 Jul 21. Cir Esp. 2017. PMID: 27453218 English, Spanish. No abstract available.